期刊文献+

丹蛭降糖胶囊对2型糖尿病胰岛素抵抗模型大鼠血脂的影响 被引量:1

Effect of Danzhi Jiangtang Capsule on the Level of Blood Fat in Model Rats of Type 2 Diabetes Insuling Resistance
下载PDF
导出
摘要 目的观察具有益气养阴活血功效的丹蛭降糖胶囊对2型糖尿病胰岛素抵抗模型大鼠血脂的影响。方法采用高热量饲料加小剂量腹腔注射链脲佐菌素(STZ)方法建立类似于2型糖尿病胰岛素抵抗的大鼠模型并分5组,测定各组大鼠治疗后的血糖、胰岛素、胰岛素敏感指数、血脂、血清游离脂肪酸(FFA)水平。结果丹蛭降糖胶囊可以降低2型糖尿病胰岛素抵抗模型大鼠的血脂。结论丹蛭降糖胶囊对2型糖尿病胰岛素抵抗大鼠血脂具有一定的改善作用。 Objective To investigate the effect of Danzhijiangtang capsule on serum fat in type 2 diabetic rats. Metheds The model of type 2 diabetes mellitus rats were established by injecting small does streptozotocin (STZ) into abdomen and feeding high sucrose-fat diet. All the rats were divided randomly into five groups. The level of blood glucose, serum insulin, insulin sensitivity index, blood fat (triglyceride, cholesterol, high-density lipoprotein, low-density lipoprotein), free fatty acid after treated were examined. Results Danzhijiangtang capsule could decrease the level of blood fat. Conclusions Danzhijiangtang capsule could improve the blood fat in type 2 diabetic rats.
出处 《中国中医药信息杂志》 CAS CSCD 2007年第5期34-35,共2页 Chinese Journal of Information on Traditional Chinese Medicine
关键词 2型糖尿病 胰岛素抵抗 丹蛭降糖胶囊 动物模型 Type 2 diabetes mellitus insulin resistance: Danzhijiangtang capsule: animal model
  • 相关文献

参考文献8

二级参考文献20

  • 1田慧,潘长玉,陆菊明,杜锦,徐向进,曹秀党.老年男性人群2型糖尿病与代谢综合征情况调查[J].中华老年多器官疾病杂志,2002,1(1):19-22. 被引量:23
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balancedoverview. Diabetes Care, 1992,15:318~368.
  • 4Storlien LH, James DE, Burleigh KM, et al. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 1986,251: E576~83.
  • 5DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol 1979,237(3):E214.
  • 6Goto Y, Kakizaki. The spontaneous--diabetes rat: a model of noninsulin dependent diabetes mellitus. Proc Japan Acad,1981 . 381~384.
  • 7Matthael S, Stumvoll M, Kellerer M, et al . Pathophysiology and Pharmacological treatment of insulin resistance.Endocrine review , 2000,21 : 585~ 618.
  • 8蔡文就,熊曼琪,朱章志,林安钟,郑高飞,贾可亮,陈芝喜,沈穗婷,何敏.实验性NIDDM大鼠模型及其胰岛素抵抗的初步研究[J].广州中医药大学学报,1997,14(2):87-91. 被引量:48
  • 9Shulman G I.Cellular mechanisms of insulin resistance[ J ].J Clin Invest,2000,106:171-176.
  • 10李晨钟.胰岛素抵抗的动物模型[J].国外医学(内分泌学分册),1998,18(3):144-147. 被引量:20

共引文献2297

同被引文献22

  • 1沈诚,范士志,陈建明,李志平,何勇.JAK/STAT通路对缺血再灌注心肌NF-κB和TNF-α表达的影响[J].中国现代医学杂志,2006,16(7):985-987. 被引量:19
  • 2SONG C D, RENG R Y, XUE L M, et al. Effect of Yishenhuox- ue recipe on activation JAK2/STAT'3 of renal tissue in the early diabetic nephropathy rats [ J ]. 中国中医基础医学杂志,2012,18(8):847-849.
  • 3ZHANG D M, LI Y C, XU D, et al. Protection of curcumin a- gainst fructose-induced hyperuricaemia and renal endothelial dys- function involves NO-mediated JAK-STAT signalling in rats [ J ]. Food Chem, 20121 134(4) : 2184-2193.
  • 4BANES-BERCEIL A K, KETSAWATSOMKRON P, OGBI S, et al. Angiotensin lI and endothelin-1 augment the vascular compli- cations of diabetes via ,IAK2 activation [ J ]. Am J Physiol Heart Circ Physiol, 2007, 293 (2) : 1291-1299.
  • 5KANDALAM U, CLARK M A. Angiotensin Ⅱ activates JAK2! STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes [ J ]. Regul Pept, 2010, 159 ( 1-3 ) :110-116.
  • 6DU J, WANG L, LIU X, et al. Janus kinase 2/signal transduc- ers and activator of transcription signal inhibition regulates protec- tive effects of probucol on mesangial cells treated with high glu- cose [J]. Biol Pharm Bull, 2010, 33(5): 768-772.
  • 7RYTrER E, VESSBY B, ASGARD R, et al. Supplementation with a combination of antioxidants does not affect glycaemic con- trol, oxidative stress or inflammation in type 2 diabetes subjects [J]. Free Radic Res, 2010, 44(12) : 1445-1453.
  • 8MATOUGH F A, BUDIN S B, HAMID Z A, et al. The role of oxidative stress and antioxidants in diabetic complications [ J ]. Sultan Qaboos Univ Med J, 2012, 12( 1 ) : 5-18.
  • 9INOGUCHI T. Role of ox'idative stress'in'iathogenesis of diabetic nephropathy [ J]. Nihon Jinzo Gakkai Shi, 2011,53 (7) : 1016- 1020.
  • 10GIUNTI S, BARUTYA F, PERIN P C, et al. Targeting the MCP-1/CCR2 System in diabetic kidney disease [ J]. Curr Vasc Pharmacol, 2010, 8(6): 849-860.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部